Jump to section
To create new ways to measure and improve health in everyday life.
Evidation Health is altering the way that the safety of new drugs and medical devices is tested. Traditionally, the world has depended upon data taken from clinical trials to measure safety, but integrating real-world data gives medical professionals a more comprehensive understanding of how new methods really impact the lives of patients.
Evidation Health has built a research platform that takes in vast amounts of real-world data. Healthcare providers can then use this data to guide medical decisions and assess the impact of diseases. The software can take input from a range of devices such as FitBit, Apple Health, Blue Button, etc., and enables data scientists to get a much better grasp of how diseases and treatments work in the real world, rather than in a lab.
The company has already worked with the Singaporean government to offer a gamification health app, LumiHealth, and has launched an influenza monitoring program "FluSmart" which is accessible through the Evidation app. This sort of constant monitoring and personalization of health data could apply to everyone on the planet, so they are operating in a huge potential market.
Kirsty
Company Specialist at Welcome to the Jungle
Mar 2021
$153m
SERIES E
Jul 2020
$45m
SERIES D
This company has top investors
Christine Lemke
(CEO)Began their career as Director of Product Management at Returns Online, before working at Microsoft and spending 5 years at Sense Networks. Co-founded Evidation in March 2012, alongside working as an Ensemble Labs Partner.
Alessio Signorini
(CTO)Having taken a PhD in AI at the University of Iowa, Alessio co-founded Spryte.it, IMRSV, and spent 3 years at Ask.com as Director of Technology.